Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:DPLO

Diplomat Pharmacy (DPLO) Stock Price, News & Analysis

Diplomat Pharmacy logo

About Diplomat Pharmacy Stock (NYSE:DPLO)

Advanced Chart
Remove Ads

Key Stats

Today's Range
$4.00
$4.01
50-Day Range
$4.00
$4.00
52-Week Range
$2.43
$14.46
Volume
744,968 shs
Average Volume
545,194 shs
Market Capitalization
$304 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Diplomat Pharmacy, Inc. operates as an independent specialty pharmacy in the United States. The company operates through Specialty and PBM (pharmacy benefit management) segment. It provides specialty infusion pharmacy, patient care coordination, clinical, compliance and persistency program, patient financial assistance, specialty pharmacy training, benefits investigation, prior authorization, risk evaluation and medication strategy, retail specialty, and hub services, as well as clinical and administrative support services to hospitals and health systems. The company primarily focuses on medication management programs for individuals with complex chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, specialized infusion therapy, and various other serious or long-term conditions. It also offers PBM services, including electronic point-of-sale pharmacy claims management, retail pharmacy network management, mail pharmacy claims management, specialty pharmacy claims management, Medicare Part D services, benefit design consultation, drug review and analysis, consulting services, data access, and reporting, information analysis, and preferred drug management programs to managed care organizations, self-insured employer groups, unions, and third-party healthcare plan administrators and worker's compensation payers. The company was founded in 1975 and is headquartered in Flint, Michigan.

Remove Ads
Receive DPLO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Diplomat Pharmacy and its competitors with MarketBeat's FREE daily newsletter.

DPLO Stock News Headlines

Trump’s Secret Weapon
Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.
See More Headlines

DPLO Stock Analysis - Frequently Asked Questions

Diplomat Pharmacy Inc (NYSE:DPLO) posted its quarterly earnings data on Tuesday, November, 12th. The company reported ($2.35) earnings per share for the quarter, missing analysts' consensus estimates of ($0.20) by $2.15. The company's revenue for the quarter was down 5.3% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that Diplomat Pharmacy investors own include Bausch Health Companies (BHC), Gilead Sciences (GILD), Bristol-Myers Squibb (BMY), Cara Therapeutics (CARA), Cannabis Sativa (CBDS), CVS Health (CVS) and Jazz Pharmaceuticals (JAZZ).

Company Calendar

Last Earnings
11/12/2019
Today
4/03/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Drug Stores & Proprietary Stores
Sub-Industry
N/A
Current Symbol
NYSE:DPLO
Fax
N/A
Employees
2,335
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-302,270,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$5.49 billion
Cash Flow
$4.60 per share
Price / Cash Flow
0.87
Book Value
$6.24 per share
Price / Book
0.64

Miscellaneous

Free Float
N/A
Market Cap
$304 million
Optionable
Optionable
Beta
0.82
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NYSE:DPLO) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners